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Summary
 
The relationship between variable (V) gene complexity and the efficiency of B cell develop-
ment was studied in strains of mice deficient in mouse antibody production and engineered
with yeast artificial chromosomes (YACs) containing different sized fragments of the human
heavy (H) chain and 
 
k 
 
light (L) chain loci. Each of the two H and the two 
 
k
 
 chain fragments
encompasses, in germline configuration, the same core variable and constant regions but con-
tains different numbers of unique V
 
H
 
 (5 versus 66) or V
 
k
 
 genes (3 versus 32). Although each of
these YACs was able to substitute for its respective inactivated murine counterpart to induce B
cell development and to support production of human immunoglobulins (Igs), major differ-
ences in the efficiency of B cell development were detected. Whereas the YACs with great V
gene complexity restored efficient development throughout all the different recombination and
expression stages, the YACs with limited V gene repertoire exhibited inefficient differentiation
with significant blocks at critical stages of B cell development in the bone marrow and periph-
eral lymphoid tissues. Our analysis identified four key checkpoints regulated by V
 
H
 
 and V
 
k
 
gene complexity: (
 
a
 
) production of functional 
 
m
 
 chains at the transition from the pre B-I to the
pre B-II stage; (
 
b
 
) productive V
 
k
 
J
 
k
 
 recombination at the small pre B-II stage; (
 
c
 
) formation of
surface Ig molecules through pairing of 
 
m
 
 chains with L chains; and (
 
d
 
) maturation of B cells.
These findings demonstrate that V gene complexity is essential not only for production of a di-
verse repertoire of antigen-specific antibodies but also for efficient development of the B cell
lineage.
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G
 
eneration of Igs by B cells is an ordered and highly
controlled process of gene recombination and expres-
sion that plays a key role in the regulation of B cell devel-
opment. This process is initiated in the bone marrow by a
series of steps in which the genes that encode the different
Ig variable segments (V, D, and J) are joined by sequential
rearrangements, followed by expression of functional Ig
molecules on the surface of B cells. Distinct developmental
stages were identified based on the rearrangement and ex-
pression of H and L chain genes and the expression of char-
acteristic sets of cell surface antigens (for a review, see refer-
ences 1 and 2). The immature pro B/pre B-I cells are
B220
 
lo
 
CD43
 
1
 
HSA
 
1
 
c-kit
 
1
 
Ig
 
2
 
 and in the process of rear-
ranging H chain genes. The more mature pre B-II cells are
B220
 
lo
 
CD43
 
2
 
HSA
 
1
 
BP-1
 
1
 
c-kit
 
2
 
CD25
 
1
 
, cytoplasmic 
 
m
 
1
 
and are rearranging the L chain genes. Finally, there are
two surface (s)Ig
 
1
 
-expressing B cell populations—the im-
mature B220
 
lo
 
m
 
hi
 
d
 
2
 
 and the mature B220
 
hi
 
m
 
lo
 
d
 
1
 
 cells.
The regulation of B cell differentiation by proper rear-
rangement and expression of the H and L chain genes is
well documented, primarily as a result of studies of mutant
mice in which mediators or 
 
cis
 
 control elements of anti-
body production were inactivated by gene targeting tech-
nology. Elucidation of structure–function relationships of
the Ig loci focused primarily on 
 
cis
 
-acting sequences 3
 
9
 
 of
the mouse V region. These studies demonstrated the im-
 
1
 
Abbreviations used in this paper:
 
 BCR, B cell receptor; h, human; m,
mouse; RAG, recombination activating gene; sIg, surface immunoglobu-
lin; SLC, surrogate light chain(s); TG, rearranged 
 
m
 
 chain transgene;
YAC, yeast artificial chromosome.
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portance of coding (e.g., J, C
 
m
 
, C
 
k
 
) and noncoding (e.g.,
E
 
m
 
, E
 
k
 
, 3
 
9
 
E, 3
 
9k
 
) sequences in regulation of antibody di-
versification, assembly, and selection (for a review, see ref-
erence 3). However, the role of the V genes, the largest
and most diverse gene family in the Ig loci, in controlling
Ig production and B cell differentiation is still not fully un-
derstood. Introduction of rearranged Ig transgenes with de-
fined single specificities into wild-type or Ig-deficient mice
demonstrated the importance of antibody surface expres-
sion and its specificity both for development and for posi-
tive and negative selection of B cells (4–8). However, these
model systems did not permit study of the effects of the V
gene pool
 
 
 
on either successful rearrangement, expression,
and assembly of functional Ig molecules, or selection and
expansion of sIg-expressing B cells. The availability of
mouse strains containing varying portions of the V
 
H
 
 or V
 
k
 
germline repertoire could clarify the extent to which the
number and complexity of the V gene repertoire influences
development of B lineage cells.
We have engineered strains of mice, collectively desig-
nated XenoMouse, that contain both inactivated mouse Ig
genes and different portions of the human H and 
 
k 
 
L chain
loci cloned on yeast artificial chromosomes (YACs; refer-
ences 9 and 10). The two human H chain YACs used, yH1
and yH2, encompass in germline configuration the same
core variable and constant sequences (D, J
 
H
 
, C
 
m
 
, C
 
d
 
), but
contain different numbers of V
 
H
 
 genes, either 5 or 66, re-
spectively. The two human 
 
k
 
 chain YACs used, yK1 and
yK2, contain in germline configuration the same J
 
k
 
 and C
 
k
 
regions, but different numbers of V
 
k
 
 genes, either 3 or 32,
respectively. Each of the combinations, yH1 and yK1 or
yH2 and yK2, restored in Ig-inactivated mice a humoral
immune system and produced fully human antibodies, indi-
cating the compatibility of these human Ig transgenes with
the mouse machinery for antibody recombination and ex-
pression (9, 10). Evaluation of antigen-specific human anti-
bodies produced by mice engineered with a limited number
of human V genes on small YACs or minigenes (9, 11, 12)
in relation to those generated by mice engineered with the
large antibody gene repertoire suggested the importance of V
gene complexity in supporting production of high-affinity
antibodies to multiple human antigens (10). These Xeno-
Mouse strains, equipped with different portions of the hu-
man V gene repertoire, also provided a unique model system
to determine the impact of the structure and content of V
gene complexity on shaping differentiation and proliferation
of B lineage cell populations. Our results reveal the critical
role of V gene complexity in supporting efficient B cell dif-
ferentiation, and demonstrate the different developmental
checkpoints controlled by V
 
H
 
 and V
 
k
 
 gene repertoire.
 
Materials and Methods
 
Mice.
 
All mice were born, bred, and kept in a barrier facility
until 1 or 2 d before killing. TG;mJ
 
H
 
2
 
/
 
2
 
 mice were generated by
breeding TG transgenic mice (with a rearranged human 
 
m
 
 transgene;
provided by M. Nussenzweig, The Rockefeller University, New
York [4]) onto the mJ
 
H
 
2
 
/
 
2
 
 background.
 
Flow Cytometry Analysis.
 
Bone marrow, peripheral blood,
and spleen were obtained from 8–10-wk-old mice, and the lym-
phocytes were separated from erythrocytes on Lympholyte M
(ACL-5035; Accurate Chemical & Scientific Corp., Westbury,
NY). Approximately 10
 
6
 
 cells for each sample were treated with
purified anti–mouse CD32/CD16 Fc receptor (01241D; Phar-
Mingen, San Diego, CA) to block nonspecific binding to Fc recep-
tors, stained with antibodies, and analyzed on a FACStar
 
PLUS
 
 using
CellQuest software (Becton Dickinson, San Jose, CA). Antibod-
ies used except where indicated were from PharMingen: FITC
anti–mouse IgM (02084D); FITC anti–human IgM (08184D);
FITC goat F(ab
 
9
 
)
 
2
 
 anti–human IgD (2032-02; Southern Biotech-
nology Associates, Inc., Birmingham, AL); FITC anti–mouse
IgD
 
a
 
 (05064D); FITC anti–mouse IgD
 
b
 
 (05074D); FITC anti–
mouse 
 
l
 
 (02174D); FITC anti-HSA (01574D); FITC anti–B7-1
(09604D); FITC anti–B7-2 (09274D); PE anti-HSA (01575A);
PE anti–human 
 
k
 
 (08175A); PE anti–mouse 
 
k
 
 (02155A); PE
anti–c-kit (0105B); PE anti-CD43 (01605B); CyChrome anti-
B220 (01128A); allophycocyanin anti-B220 (01129A); biotin anti–
human IgM (08072D); biotin anti–mouse IgM (02202D); biotin
anti-CD25 (01092D); and biotin anti-6C3 (01282D). RED613
 
Ô
 
-
streptavidin (19541-010; GIBCO BRL, Gaithersburg, MD) was
used to detect biotinylated antibodies.
 
In Vitro Proliferation Assays.
 
Spleens from three to eight mice
of each genotype were isolated and ground with a frosted glass
microscope slide. The cell suspension in DME was then spun
over a Lympholyte M step gradient. Lymphocytes at the gradient
interface were collected and washed twice in DME, then resus-
pended in a solution of PBS, 5 mM EDTA, and 0.5% FCS. T
cells and macrophages were depleted from the spleen cell suspen-
sions by magnetic cell sorting using anti-CD5 and anti-CD11b
magnetic beads (493-01 and 496-01; Miltenyi Biotec Inc., Au-
burn, CA) and a Type B column according to the manufacturer’s
instructions. Enrichment for live B cells was assayed by staining
the cells for B220 and 
 
m
 
 and with propidium iodide before and
after depletion, followed by FACS
 
Ò
 
 analysis. This treatment re-
sulted in a 70–90% B220
 
1
 
m
 
1
 
 cell population. For each assay, 1.5 
 
3
 
10
 
5
 
 live B220
 
1
 
m
 
1
 
 cells were grown in 96-well plates in DME
supplemented with 10% FCS, 2 mM glutamine, and penicillin-
streptomycin plus one of the following: LPS at a final concentra-
tion of 20 
 
m
 
g/ml, goat anti–mouse IgM F(ab
 
9
 
)
 
2
 
 (115-006-075;
Jackson ImmunoResearch Labs, West Grove, PA) at a final con-
centration of 150 
 
m
 
g/ml, goat anti–human IgM F(ab
 
9
 
)
 
2
 
 (109-006-
043; Jackson ImmunoResearch Labs) at a final concentration of
150 
 
m
 
g/ml, or medium alone as a negative control. After 2 d in-
cubation at 37
 
8
 
C, 1 
 
m
 
Ci [
 
3
 
H]thymidine (1 mCi/ml; Amersham
Corp., Arlington Heights, IL) was added to each well, and after an
additional 1 d of incubation, the samples were counted for incor-
poration of label into DNA. Each sample was assayed in triplicate.
 
Results
 
The effect of increasing V gene repertoire on antibody
production and B cell development was evaluated in Ig-inac-
tivated mice engineered with either of two pairs of human
H and 
 
k
 
 chain Ig YACs—yH1 and yK1, or yH2 and yK2
(Fig. 1). The yH1 H chain YAC had a 220-kb insert of the
human IgH locus, containing in germline configuration the
 
m
 
 and 
 
d
 
 constant regions, the intronic enhancer, all six func-
tional J
 
H
 
 regions, the entire D complex, and the five most
proximal variable genes from four V
 
H
 
 families (Fig. 1; ref-
erences 9 and 13). The yH2 H chain YAC contained the 
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entire yH1 YAC as the core and 61 additional upstream V
 
H
 
genes (34 functional V
 
H 
 
in total), all in germline configura-
tion, plus the human 
 
g
 
2 constant region (C
 
g
 
2) and the
murine 3
 
9
 
 enhancer (m3
 
9
 
E) appended downstream of C
 
d
 
(10). The 
 
k
 
 L chain YAC, yK1, had a 170-kb insert con-
taining in germline configuration the 
 
k deleting element,
the intronic and 39 enhancers, the Ck region, all five func-
tional Jk regions, and the three most proximal Vk regions
in the B cluster, two of which are functional (9, 13). The
larger k chain YAC, yK2, had an 800-kb insert, with yK1
at the core and 29 additional Vk genes from the proximal
Vk cluster, with 18 functional Vk genes in total (10).
Mice homozygous for both the inactivated mouse H and
the inactivated k chain alleles (DI) were generated as de-
scribed previously (9). Into this DI genetic background, we
introduced either the yH1 and yK1, or the yH2 and yK2
transgenes to yield XenoMouse I or XenoMouse II strains,
respectively. Using these strains, we evaluated the ability of
these human H and k L chain loci to restore B cell devel-
opment and to produce fully human antibodies. To dem-
onstrate the ability of individual H or k chain transgenes to
replace their corresponding mouse counterparts, intermedi-
ate mouse strains were generated. One set of mouse strains
was generated with either yH1 or yH2 on a mouse H
chain–inactivated background (yH;mJH
2/2) (14). Another
set of mouse strains was generated with yK1 or yK2 on a
mouse k chain–inactivated background (yK;mCk2/2).
B cell populations in the bone marrow and peripheral
lymphoid tissues were analyzed by multiparameter flow cy-
tometry, staining for cell surface markers specific to differ-
ent stages of development. Precursor B cell populations
were separated as described by Hardy and Hayakawa using
the differential expression of B220, CD43, HSA, and BP-1
(1), or by Rolink and Melchers using the expression of
B220, m, c-kit, CD25, and cell size (2). These two systems
complemented each other and allowed the identification of
the developmental stages controlled by the V gene reper-
toire on both the human H and k chain loci.
A Large Human VH Gene Repertoire Supports Efficient B
Cell Development in mJH
2/2 Mice. The ability of the H chain
YACs, yH1 and yH2, to restore B cell development was
first evaluated in mice homozygous for the JH deletion
(mJH
2/2) and engineered with one of these YACs. JH-inac-
tivated mice were devoid of mature B cells (B2201m1) and
deficient in antibody production (Fig. 2, A and E; refer-
ences 9 and 14). The bone marrow from mJH
2/2 mice lacked
B2201m1 cells due to terminal arrest of B cell development
at the pro B/pre B-I, B2201m2c-kit1CD252 stage (Fig. 2,
A and B). By Hardy’s convention, developing pro B/pre
B-I cells at Fraction B (B2201CD431HSA1BP-12) accu-
mulated to levels three- to fourfold over wild-type, and
terminally arrested at Fraction C (B2201CD431 HSAmed
BP-11) (Fig. 2 D). The inability to develop beyond the pro
B/pre B-I stage was consistent with a block in H chain re-
arrangement at the stage of DH-JH recombination (1–3).
The presence of one allele of the yH1 transgene in
mJH
2/2 mice partially alleviated the arrest at the pro B/pre
B-I stage, resulting in incomplete reconstitution of B cell
compartments with B2201hm1 cells (Fig. 2 A) and forma-
tion of human m chain–containing antibodies (9). Pro B/
pre B-I cells in yH1;mJH
2/2 bone marrow successfully de-
veloped into large pre B-II (B2201m2c-kit2CD251) or
B2201CD431HSAhiBP-11 (Fraction C9) cells, although at
levels z30% of wild-type mice (Fig. 2, B–D). The partial
differentiation was consistent with the continued accumu-
lation of pro B/pre B-I cells at the B2201m2c-kit1CD252
Figure 1. Schematic represen-
tation of human H and k chain
YACs introduced into Xeno-
Mouse strains I and II. The
structure of human Ig YACs in
XenoMouse I (yH1, yK1) and II
(yH2, yK2) with respect to the
human Ig loci (references 41 and
42), their sizes, and non-Ig se-
quences are indicated (not
shown to scale). The YAC vec-
tor elements telomere (arrow-
head), centromere (black circle),
mammalian (HPRT, Neo), and
yeast (TRP1, ADE2, LYS2,
URA3) selectable markers on the
YAC vector arms are indicated.
VH segments are classified as
genes with open reading frame
(black circle), pseudogenes (white
square), and nonrearranged genes
with open reading frames that
can also be classified as pseudo-
genes (gray circle; reference 43).
Vk segments are classified as
genes with open reading frames
(black circle) and pseudogenes
(white  square).486 Regulation of B Cell Development by V Gene Complexity
stage or at Fraction B, similar to that observed in mJH
2/2
mice. Cell accumulation was also detected in the Fraction
C compartment, which was three- to fourfold larger than in
both wild-type and mJH
2/2 mice. A reconstitution level of
z50% was detected at the small pre B-II stage (Fig. 2 C)
and was sustained in the newly emerging B220lom1 B cell
population (Fig. 2 A). However, the levels of mature, re-
circulating B220him1 cells dropped to only 10% of wild-
type. Consistent with the mature B cell population in bone
marrow, spleens of yH1;mJH
2/2 mice exhibited z10% B cell
reconstitution (Fig. 2 E). The percentage of B2201m1 cells
that were d1HSAlo in the spleen was similar to that of wild-
type mice, demonstrating normal differentiation to mature
B cells in yH1;mJH
2/2 (reference 15, and data not shown).
The proper pairing between human m protein and mouse k
and l L chains was supported by the wild-type–like L chain
distribution on the mouse B cells (k/l 5 95:5; not shown).
These results indicate that yH1 can induce complete but
inefficient B cell differentiation in H chain–inactivated mice,
leading to a partial reconstitution of mature B cell popula-
tions in the different lymphoid organs. The stage at which
the differentiation block is observed (Fractions B and C)
suggests that a large fraction of pro B/pre B-I cells are un-
able to complete a productive VDJ rearrangement and/or
to express a m protein capable of pairing with surrogate L
chains (SLC) and forming a pre B cell receptor (pre-BCR),
a prerequisite for differentiation to the pre B-II cell stage (3).
The effect of a second yH1 allele on B cell development
was evaluated in mice homozygous for the YAC (yH1/
yH1;mJH
2/2). This strain exhibited a twofold increase in B
cell reconstitution over the hemizygous strain, starting at
stages correlated with completion of a productive VDJ re-
arrangement and m chain expression. Accumulation of cells
at the pro B/pre B-I stage in yH1/yH1;mJH
2/2 mice was
still observed (Fig. 2 B). However, the large pre B-II popu-
lation was 50% of wild-type, and the small pre B-II popula-
tion (or Fraction D) reached wild-type levels (Fig. 2, C and
D). The newly emerging B220lom1 cells were z80% of
wild-type, but the mature, recirculating B220him1 cells
demonstrated a 20% reconstitution level, similar to that ob-
served in the spleen and double the levels detected in yH1;
mJH
2/2 mice (Fig. 2, A and E). A proportional increase in
the percentage of mature B2201HSAlom1d1 cells in the
spleen of yH1/yH1;mJH
2/2 mice relative to yH1;mJH
2/2
mice was detected as well (not shown). Human m in yH1/
yH1;mJH
2/2 serum, averaging 60 mg/ml, represented 10%
of the mouse m serum levels in wild-type mice housed in
the same pathogen-free facility. Thus, the second yH1 al-
lele in mJH
2/2 mice doubled the population of B cells that
completed productive VDJ recombination, expressed sur-
face m protein, and progressed to mature B cells.
To test the effect of increased VH repertoire on B cell
development, the yH2 transgene was bred onto the mJH
2/2
background. yH2 was able to improve significantly all
stages of B cell development and reconstitution in bone
marrow and in the peripheral lymphoid compartments.
yH2 fully relieved the accumulation of developing B cells
at the pro B/pre B-I stage observed in yH1-bearing mJH
2/2
Figure 2. Restoration of B cell develop-
ment by yH transgenes in mJH
2/2 mice.
Analysis of bone marrow (A–D) or spleen
(E) of wild-type (WT), JH-deleted (mJH
2/2),
hemizygous yH1;mJH
2/2, homozygous
yH1/yH1;mJH
2/2, hemizygous yH2;mJH
2/2,
or TG;mJH
2/2 mice. Four-color flow cy-
tometry was performed using antibodies
against (A) B220 and mouse or human m;
(B) c-kit and CD25 in the B2201m2 popu-
lation gated from A; (C) forward scatter size
distribution of the B2201m2c-kit2CD251
population gated from B; (D) HSA and BP-1
in the B2201CD431 gated population; and
(E) B220 and mouse or human m. The per-
centage of positive cells within a quadrant
or region is indicated. The data shown are
representative of those obtained from multi-
ple animals. The mean numbers of
B2201m1 cells in the spleen were 39 6 2 3
106 for wild-type (n 5 3), 0 for mJH
2/2 (n 5
3), 2 6 2 3 106 for yH1;mJH
2/2 (n 5 3), 5 6
2 3 106 for yH1/yH1;mJH
2/2 (n 5 7), 22 6
5 3 106 for yH2;mJH
2/2 (n 5 5), and 25 6
7 3 106 for TG;mJH
2/2 mice (n 5 5). The
mean numbers of B2201m2 cells in the
bone marrow were 4.7 6 1.4 3 106 for
wild-type (n 5 3), 2.4 6 0.7 3 106 for
mJH
2/2 (n 5 3), 5.5 6 0.2 3 106 for yH1;
mJH
2/2 (n 5 3), 8.4 6 3.8 3 106 for yH1/
yH1;mJH
2/2 (n 5 7), 3.5 6 1.0 3 106 for
yH2;mJH
2/2 (n 5 5), and 1.5 6 0.7 3 106
for TG;mJH
2/2 mice (n 5 5).487 Green and Jakobovits
strains and restored fully the large and small pre B-II popu-
lations (Fig. 2, B–D). Reconstitution was also complete in
the newly emerging B cell population, but it decreased to
z70% of wild-type in the mature, recirculating B cell pop-
ulation in both the bone marrow and spleen (Fig. 2, A and
E). However, this decrease in reconstitution level upon
maturation from B220lom1 to B220him1 was significantly
lower than that observed in yH1-bearing mJH
2/2 strains.
Consistent with the improved B cell development, the lev-
els of circulating human m and g2 chains in sera from yH2;
mJH
2/2 mice averaged 200 mg/ml for both, only twofold
lower than the mouse m levels in normal mice kept under
pathogen-free conditions.
yH2 differed from yH1 not only by its increased VH
gene content but also by the presence of the human Cg2
and the m39E sequences. To study the contribution of
these downstream sequences to the improved restoration of
B cell development by the yH2 YAC, mJH
2/2 mice bear-
ing a yH2m YAC transgene, containing all of yH2 except
for the human Cg2 and the m39E sequences, were ana-
lyzed. Similar to the yH2 hemizygous strain, yH2m;mJH
2/2
mice exhibited complete reconstitution of all stages of B
cell development, up to and including the newly emerging
B cell compartment, and a mature B cell population z70%
of wild-type (not shown). These results indicate that the
human Cg2 and m39E sequences are dispensable for the
improved reconstitution of B cell development by yH2,
and that the enhanced B cell development was the result of
the increased number and complexity of the VH genes.
We compared reconstitution of B cell development in
mJH
2/2 mice by the H chain YACs to that obtained by a
rearranged human m transgene (TG). TG had previously
been shown to be expressed at significant levels on mouse
B cells resulting in a complete allelic exclusion of the mu-
rine H chains in wild-type mice (4), and to support B cell
development in recombination activating gene (RAG)-
deficient mice (7). Consistent with previous observations
(7), TG;mJH
2/2 mice had greatly reduced populations at
the pro B/pre B-I, large and small pre B-II, and the newly
emerging B cell stages, probably due to the acceleration of
B cell development by early expression of the rearranged m
transgene (Fig. 2). Reconstitution of mature B2201m1
populations in the bone marrow and spleen was z50 and
70% of wild-type mice, respectively, similar to that ob-
served in yH2;mJH
2/2 mice (Fig. 2 A). Thus, a partially re-
constituted mature B cell population was also obtained
with a rearranged human transgene, which is properly ex-
pressed and selected in wild-type mouse B cells. This ob-
servation may indicate that other components, in addition
to a large VH repertoire, are required for complete matura-
tion and/or expansion and survival of the recirculating
B2201m1 cells (see Discussion).
The Increased Vk Complexity on yK2 Resulted in Functional
Replacement of the Mouse k Locus. The ability of yK1 and
yK2 YACs to substitute for the inactivated mouse k chain
locus was first evaluated in mice homozygous for the dele-
tion of mouse Ck (mCk2/2). These mice displayed a com-
plete absence of k1 B cells, and all B cell populations ex-
pressed the mouse l L chain exclusively (Fig. 3). Analysis
of the different B cell subpopulations in the bone marrow
demonstrated a wild-type–like distribution in the develop-
mental stages that precede L chain expression, the pro B/
pre B-I and the large pre B-II populations (not shown).
However, a twofold accumulation at the small pre B-II
stage was detected (Fig. 3 B). As a result of the partial dif-
ferentiation arrest, the newly emerging B cell compartment
and the mature recirculating population reached only 50–
60% of wild-type levels (Fig. 3 A), consistent with previous
reports (16). In the serum of mCk2/2mice, levels of circu-
lating mouse l chains averaged 580 compared with 70 mg/
ml in wild-type mice. These results indicate that the mouse
l locus can substitute for the inactivated k locus only par-
tially, resulting in a lower efficiency of differentiation to
sIg-expressing B cells.
The first human k transgene tested, yK1, with its three
Vk genes, two of which are functional, could partially re-
place the inactivated mouse k locus and compete with the
mouse l chain genes. mCk2/2 mice with either one or
two yK1 alleles exhibited an accumulation at the small pre
B-II stage (Fig. 3, A and B). The percentage of newly
emerging B220lom1 B cells in yK1 hemizygous or homozy-
gous mice, relative to the mCk2/2 mice, increased to z70
and 100% of wild-type mice, respectively, whereas their
mature bone marrow B220him1 populations did not change
significantly (Fig. 3 A). The B cell populations in the periph-
eral blood and lymph nodes of the yK1-bearing mCk2/2
strains increased by 20–25% over mCk2/2 mice, indicating
improved B cell development by the yK1 YAC (Fig. 3, C
and D).
Another manifestation of the ability of the yK1 YAC to
compete effectively with the mouse l chain and restore k
chain expression in mCk2/2 mice was the appearance of a
significant human k1 B cell population, in particular in the
presence of two yK1 alleles. In peripheral blood (Fig. 3 E),
lymph nodes, and spleen (data not shown) of yK1;mCk2/2
mice, there were equivalent numbers of hk1 and ml1 B
cells, whereas in yK1/yK1;mCk2/2 mice, hk1 B cells out-
numbered ml1 B cells by a 2:1 ratio. Similar results were
observed in the newly emerging B220lom1 population in
the bone marrow, indicating that the preferential usage of
human k over mouse l occurs at the stage of L chain rear-
rangement, as shown previously for wild-type mice (17).
The circulating human Igk levels in yK1 homozygotes
were higher than those detected in the hemizygotes, aver-
aging 720 and 250 mg/ml, respectively. The levels of circu-
lating mouse l chain were reduced in both strains to z300
mg/ml.
The second human Igk transgene, yK2, with its in-
creased Vk repertoire, was able to substitute fully for the
mouse k chain locus and to dominate L chain use. Both
hemizygous and homozygous yK2;mCk2/2 mice exhibited
full restoration of B cell development in the bone marrow,
with a complete relief of the cell accumulation at the small
pre B-II stage detected in both mCk2/2 and yK1;mCk2/2488 Regulation of B Cell Development by V Gene Complexity
mice and the appearance of wild-type–like newly emerging
and mature B cell populations (Fig. 3, A and B). Complete
reconstitution of B cell compartments was also detected in
the peripheral blood, lymph nodes (Fig. 3, C and D), and
spleen (not shown) of yK2;mCk2/2 mice.
The apparent ability of yK2 to substitute for the mouse
Igk locus was also observed at the level of hk1-expressing
B cells (Fig. 3 E). In hemizygous yK2;mCk2/2 mice, the
majority of the peripheral blood lymphocytes (z75%) ex-
pressed human k chain exclusively, whereas only a minor-
ity (15%) expressed mouse l chain. A similar k to l chain
distribution was detected in mice with only one functional
mouse Igk locus (16). In yK2/yK2;mCk2/2 mice, the hu-
man k1 B cell population increased to .90%, and the
Figure 3. Restoration of B cell develop-
ment by yK transgenes in mCk2/2 mice.
Analysis of bone marrow (A and B), periph-
eral blood lymphocytes (C and E), or lymph
nodes (D) of wild-type (WT), Ck-deleted
(mCk2/2), hemizygous yK1;mCk2/2; ho-
mozygous yK1/yK1;mCk2/2, hemizygous
yK2;mCk2/2, or homozygous yK2/yK2;
mCk2/2 ( E  only) mice. Four-color flow
cytometry was performed using antibodies
against (A) B220 versus mouse m; (B) for-
ward scatter size distribution of the gated
B2201m2c-kit2CD251 population; (C and
D) B220 and mouse m; and (E) mouse k or
human  k and mouse l in the gated
B2201m1 population. The percentage of
positive cells within a quadrant or region is
indicated. The data shown are representa-
tive of those obtained from multiple ani-
mals. The mean numbers of B2201m1 cells
in the spleen were 33 6 4 3 106 for wild-
type (n 5 3), 11 6 2 3 106 for mCk2/2 (n 5
3), 19 6 4 3 106 for yK1;mCk2/2 (n 5 6),
20 6 6 3 106 for yK1/yK1;mCk2/2 (n 5
6), and 25 6 8 3 106 for yK2;mCk2/2
mice (n 5 5). The mean numbers of
B2201m1 cells in the blood and lymph
nodes were not assayed. The percentages of
B2201m1 cells in the spleens of the mice
shown in the figure were 54.0 for wild-type,
38.7 for mCk2/2, 47.0 for yK1;mCk2/2,
47.9 for yK1/yK1;mCk2/2, and 56.6 for
yK2;mCk2/2 mice. The mean numbers of
B2201m2 cells in the bone marrow were 3.2
6 1.9 3 106 for wild-type (n 5 3), 9.9 6 3.7
3 106 for mCk2/2 (n 5 3), 12.2 6 4.7 3
106 for yK1;mCk2/2 (n 5 6), 9.3 6 5.0 3
106 for yK1/yK1;mCk2/2 (n 5 6), and 6.2
6 4.3 3 106 for yK2;mCk2/2 mice (n 5 6).
Table 1. The yK2 Transgene Competes Effectively with the Murine Igk Locus
Genotype
yK2/mIgk* % hk1 % mk1 % ml1 yH2 yK2 mJH mCk
22 1 / 11 / 1 0:2 0.1 6 0.1 90.0 6 0.8 2.6 6 0.3
21 1 / 11 / 2 1:1 40.2 6 2.3 39.4 6 2.9 4.6 6 0.4
11 2 / 21 / 2 1:1 34.8 6 4.0 37.1 6 1.6 11.2 6 5.3
11 / 12 / 21 / 2 2:1 52.9 6 2.3 25.0 6 0.8 6.5 6 1.3
B splenocytes were stained with antibodies against B220, human k, and mouse k, or B220, mouse k, and mouse l, then analyzed by three-color
flow cytometry. The B2201 population was first gated, then analyzed for expression of other markers. The percentages of cells positive for human k,
mouse k, or mouse l were determined. Data are presented as the average 6 SD. Three mice of each genotype were tested.
*The ratio of functional alleles for each locus.489 Green and Jakobovits
mouse l1 B cell population decreased to 5%, reaching a
wild-type–like k to l distribution ratio. Similar results
were obtained in the spleen and lymph nodes, and in the
newly emerging B220lom1 and mature B220him1 cells in
the bone marrow (not shown). The average levels of circu-
lating hk and ml in yK2;mCk2/2 mice were 1,400 and
100 mg/ml, respectively, equivalent to the levels of mouse
k and l in wild-type mice kept under similar conditions.
As the only known difference between the yK1 and yK2
YACs resides in the number and diversity of their V genes,
these results provide evidence for the role of Vk gene rep-
ertoire in supporting normal k chain recombination and
expression.
Equivalency of the human k chain locus on yK2 with
the mouse Igk locus was further demonstrated in mice with
one functional mIgk allele and either one or two alleles of
yK2 (Table 1). In the peripheral blood of mice with func-
tional H chain loci, one functional mIgk allele, and one
yK2 allele (yK2;mCk1/2), the percentages of hk1 and mk1
B cells were equivalent (Table 1). Similarly, equivalent us-
age of yK2 and mIgk in a yH2;mJH
2/2 background (yH2;
yK2;mJH
2/2;mCk1/2 mice) was demonstrated. In mice
with two yK2 alleles and one functional mIgk allele (yH2;
yK2/yK2;mJH
2/2;mCk1/2), the ratio of hk1 to mk1 B
cells in the spleen increased to 2:1 (Table 1). Thus, yK2
competes effectively with the mouse k chain locus. These
data also demonstrated the lack of an apparent preference of
the H chain for a k chain of the same species.
Increased VH and Vk Gene Repertoires Restore Efficient B
Cell Development in XenoMouse Strains. The combined ef-
fects of yH1 and yK1 or yH2 and yK2 in replacing their in-
activated mouse counterpart loci, thereby restoring B cell
development and inducing human antibody production in
DI (mJH
2/2;mCk2/2) mice, was examined in the Xeno-
Mouse I (yH1;yK1;DI) and II (yH2;yK2;DI) strains. In the
bone marrow of DI mice, the pattern of arrested B cell
development was similar to that observed in mJH
2/2 mice.
Developing B cells accumulated at the pro B/pre B-I stage
(Fraction B) and were terminally arrested at Fraction C,
or the B2201m2c-kit1CD252 stage (Fig. 4; references 9
and 10).
As demonstrated above (Figs. 2 and 3), a second yH1 al-
lele affected B cell development in yH1;mJH
2/2 mice sig-
nificantly, whereas only a small effect was observed with a
second yK1 allele in yK1;mCk2/2 mice. Moreover, no ob-
vious differences in reconstitution of B2201m1 compart-
ments in XenoMouse strains with one versus two alleles of
either yK1 or yK2 were observed (not shown). Therefore,
we concentrated on analyzing B cell development in Xeno-
Mouse I and II strains homozygous for the yK transgenes,
in conjunction with either one or two alleles of the yH
transgene.
yH1 in conjunction with yK1 partially restored B cell
development and B2201hm1hk1 compartments in Xeno-
Mouse I. Similar to yH1;mJH
2/2 strains, XenoMouse I
strains with one or two yH1 alleles still exhibited a three-
fold accumulation of developing B cells at the pro B/pre
B-I stage (B2201m2c-kit1CD252 or Fraction B; Fig. 4, B
and D). XenoMouse with one yH1 allele had z30% of
wild-type levels at Fraction C9 (or the large pre B-II stage),
whereas the homozygous strain exhibited z60% reconsti-
tution level. The sizes of B cell populations in Fractions D
and E in XenoMouse I were substantially lower than the
respective ones in the yH1;mJH
2/2 or yK1;mCk2/2 mouse
strains (Figs. 2–5). Hemizygous and homozygous Xeno-
Mouse I strains represented reconstitution levels of 30 and
70% for the small pre B-II cells, and 10 and 30% for the
newly emerging and mature B2201m1d1 populations.
These results illustrated a consistent twofold improvement
Figure 4. Restoration of B cell development in bone marrow of Xeno-
Mouse I. Analysis of bone marrow (A–E) of wild-type (WT), DI (mJH
2/2;
mCk2/2), XenoMouse I hemizygous for yH1 and homozygous for yK1,
and XenoMouse I homozygous for yH1 and yK1. Four-color flow cy-
tometry was performed using antibodies against (A) B220 and mouse or
human m; (B) c-kit and CD25 in the B2201m2 population gated from A;
(C) forward scatter size distribution of the B2201m2c-kit2CD251 popu-
lation gated from B; (D) HSA and BP-1 in the B2201CD431 gated pop-
ulation; and (E) mouse d and mouse m or human d and human m in the
B2201CD432 gated population. The percentage of positive cells within a
quadrant or region is indicated. The data shown are representative of
three wild-type, three DI, and eight XenoMouse I mice of each geno-
type. The mean numbers of B2201m2 cells in the bone marrow were 6.5 6
2.5 3 106 for wild-type, 2.4 6 1.6 3 106 for DI, 4.7 6 1.7 3 106 for
yH1;yK1/yK1;DI, and 9.3 6 3.5 3 106 for yH1/yH1;yK1/yK1;DI. The
mean numbers of B220lom1 cells in the bone marrow were 2.8 6 1.1 3
106 for wild-type, 0.5 6 0.2 3 106 for yH1;yK1/yK1;DI, and 1.1 6 0.4 3
106 for yH1/yH1;yK1/yK1;DI. The mean numbers of B220him1 cells in
the bone marrow were 2.8 6 1.1 3 106 for wild-type, 0.2 6 0.1 3 106
for yH1;yK1/yK1;DI, and 0.5 6 0.2 3 106 for yH1/yH1;yK1/yK1;DI.490 Regulation of B Cell Development by V Gene Complexity
in B cell development by the second yH1 allele, which was
also manifested in the spleen (Fig. 6 A, and data not
shown). In the B2201m1 compartment of XenoMouse I,
there was an overrepresentation of B2201HSAhi cells and
an underrepresentation of the mature B2201HSAlo cells
compared with wild-type (Fig. 6 B). The B2201 popula-
tion had a twofold lower level (50% of wild-type) of
hm1hd1 cells. The B2201HSAlo cells were CD52CD401
(not shown). These results indicate that yH1 and yK1 are
capable of restoring the progression of precursor B cells
through development and maturation, but with a limited
efficiency that is likely to reflect the combined deficiencies
associated with the small VH and Vk gene repertoires (see
Discussion).
We then evaluated the potency of yH2 and yK2, with
their greatly increased V gene repertoires, for improving B
cell development in XenoMouse II strains compared with
the respective intermediate strains. Complete reconstitu-
tion of the pro B/pre B-I and the large and small pre B-II
populations in the bone marrow of XenoMouse II was ob-
served (Fig. 7), consistent with results from both yH2;
mJH
2/2 and yK2;mCk2/2 strains. The newly emerging
B2201m1d2 and the mature B220him1d1 populations both
exhibited reconstitution of 50–70%. These reconstitution
levels were similar to those detected in yH2;mJH
2/2 mice,
whereas complete restoration of the B220him1 population
was demonstrated in yK2;mCk2/2 mice (Figs. 2, 3, and 5).
In the spleen of XenoMouse II, the B2201m1 popula-
tion exhibited z70% reconstitution level (Fig. 6 A).
Within this compartment, the ratio of HSAhi (immature) to
HSAlo (mature) B cells was reminiscent of that detected in
wild-type mice, with both immature and mature popula-
tions z70% of wild-type (Fig. 6 B). Furthermore, within
the XenoMouse II B2201 population, the ratio of m1d1 to
m1d2 cells was identical to wild-type mice (Fig. 6 C). The
majority (80%) of the B2201HSAlo B cells in XenoMouse
II spleen were hm1hd1 and CD52CD401, identical to the
mm1md1 cells in the B2201HSAlo population in wild-type
mice (not shown). Thus, the yH2 and yK2 YACs sup-
ported proper maturation of XenoMouse II B cells to
HSAlom1d1. The percentages of hk1- and ml1-expressing
B cells were identical to the L chain distribution in wild-
type mice (Fig. 6 D). The restoration of normal B cell de-
velopment in XenoMouse II was also manifested in circu-
lating levels of human m and k chains (300 and 530 mg/ml,
respectively) that were higher than those detected in Xeno-
Mouse I (150 and 120 mg/ml, respectively). The average
levels of hg2 in XenoMouse II were 100–200 mg/ml.
Mouse l levels were lower in XenoMouse II compared
with XenoMouse I—10 versus 40 mg/ml.
A similar reconstitution pattern of the B cell lineage by
yH2 and yK2 was observed in XenoMouse II.3 (Fig. 6), a
mouse strain in which the two YACs were cointegrated on
the same chromosome by fusing embryonic stem cells with
a yeast strain containing both the yH2 and yK2 YACs. In
transgenic mice, the two transgenes cosegregated through
.1,000 progeny, strongly suggesting close genetic linkage.
In the XenoMouse II.3 spleen, B cell reconstitution was
Figure 5. Summary of B cell
development in the bone mar-
row of Ig-inactivated mice engi-
neered with yH and yK YACs.
Restoration values of B cell pop-
ulations at the different develop-
mental stages, for each of the
mouse strains analyzed, are given
relative to those of wild-type
mice (WT), which are presented
as 100%. The data are represen-
tative of average values for mul-
tiple animals (see other figure
legends). The mouse strains are
presented by the genotypes of
yH and yK transgenes on the
mouse Ig-inactivated back-
grounds. Stages of B cell devel-
opment and the correlated status
of H and L chain rearrangement
are outlined according to Rolink
and Melchers (reference 2) or
Hardy and Hayakawa (reference
1). The comparison of the two
systems represents only our best
approximation of the correlation.
G, Ig genes in germline configu-
ration;  arrows, Ig genes in the
process of rearrangement. Shad-
ing, Percentages of the cells at
each developmental stage, rela-
tively proportional to that in
wild-type mice. Fr, Fraction.491 Green and Jakobovits
70% of wild-type, and the majority of the B cells were
B2201HSAlom1d1, as observed in the XenoMouse II strain
(Fig. 6). However, a higher percentage of mouse l1-express-
ing B cells was observed in the periphery of XenoMouse
II.3 compared with XenoMouse II strains (Fig. 6 D). Se-
rum Ig levels in the XenoMouse II.3 strain were higher
than in XenoMouse II, with average levels of 420 mg/ml
for hm, 700 mg/ml for hg2, and 600 mg/ml for hk. Thus,
human H and k chain loci, when arrayed in cis-configura-
tion on the same chromosome, can support essentially
proper recombination and expression of both chains and
induce efficient B cell development.
H Chain YACs Support Proper Proliferation of Mouse B
Cells. Formation of a functional BCR complex, through
assembly of the m chain with the other components such as
Iga and Igb, is a prerequisite for transduction of prolifera-
tion signals (18). The ability of mouse B cells expressing
yH-encoded human m chains to respond properly to prolif-
eration signals such as LPS and anti-m antibodies was evalu-
ated. Proliferation of B cells from spleens of yH1;mJH
2/2,
yH2;mJH
2/2, or yH2m;mJH
2/2 (not shown) mice was
equivalent to that of wild-type mouse B cells after in vitro
stimulation with either LPS (Fig. 8 A) or anti-m F(ab9)2 an-
tibodies (Fig. 8 B). Induction of expression of B7-1 and
B7-2, surface markers for B cell activation, was also ob-
served (not shown). These results indicate that the human
H chains encoded by both yH1 and yH2 YACs can func-
tionally substitute for their murine counterparts in the
BCR complex and can support B cell proliferation in vitro.
The functionality of XenoMouse-derived B cells in vivo was
confirmed by the ability of these mice to mount a strong hu-
man antibody response to multiple antigens and to produce
high-affinity fully human mAbs against different antigens, in-
cluding human IL-8, human TNF-a, and the human epi-
dermal growth factor receptor (10).
Discussion
This report elucidates the role of the size and complexity
of the native human antibody repertoire in shaping B cell
differentiation and proliferation pathways by directly com-
paring B cell development in XenoMouse strains transgenic
for segments of the human H and k chain loci differing
only in the spectrum of their V gene repertoire. As the V
gene arrays on the integrated Ig YACs are in germline con-
figuration and in a single copy, our study evaluated the hu-
man H and k variable gene repertoires in their native orga-
nization and structure. Furthermore, the availability of
XenoMouse and their precursor strains bearing only a hu-
man H or k chain YAC allowed us to study both the dis-
crete and the combined contribution of each of the VH or
Vk gene repertoires to B cell development, and the pairing
compatibility of the human and mouse Ig chains.
Our studies identified four developmental stages affected
by V gene complexity (Fig. 5): (a) production of a func-
tional m chain at the transition from pre B-I to pre B-II
stage; (b) productive recombination of VkJk genes; (c) for-
mation of functional Ig molecules by pairing of specific m
Figure 6. B cell maturation in spleen of
XenoMouse I and XenoMouse II strains.
Analysis of B splenocytes from wild-type
(WT), DI (mJH
2/2; mCk2/2), XenoMouse I
(homozygous for yH1 and yK1), Xeno-
Mouse II (hemizygous for yH2; homozy-
gous for yK2), and XenoMouse II.3 (ho-
mozygous yH2 and yK2) mice. Four-color
flow cytometry was performed using anti-
bodies against (A) B220 versus mouse or
human  m; (B) HSA and B220; (C) mouse d
and mouse m or human d and human m in
the gated B2201 population; (D) mouse l
and mouse k or human k in the gated
B2201m1 population. The percentage of
positive cells within a quadrant or region is
indicated. The data shown are representa-
tive of multiple animals. The mean numbers
of B2201m1 cells in the spleen were 68 6
13 for wild-type (n 5 3), 0 for DI (n 5 3),
15 6 3 for XenoMouse I (n 5 4), and 24 6
15 for XenoMouse II (n 5 10).492 Regulation of B Cell Development by V Gene Complexity
and conventional L chains; and (d) maturation to recirculat-
ing B cells. All of these checkpoints are critical to successful
B cell development. Therefore, any decline in the effi-
ciency of cell progression at these stages can severely impair
the entire humoral immune system, as demonstrated in this
report.
The first developmental checkpoint regulated by VH
gene complexity is the production of a functional m pro-
tein. yH1, the human H chain YAC with core variable and
constant sequences and only five VH genes, was sufficient to
relieve the block at H chain gene recombination in JH
2/2
mice and to induce B cell differentiation all the way to mature
B cells, but only in a small fraction of the precursor B cells
(Fig. 2). Accumulation of the majority of the yH1;mJH
2/2 B
cell population in Fractions B and C is indicative of a re-
duced efficiency in completing productive VH-DJH recom-
bination and/or an impaired ability of the generated m pro-
tein specificities to pair successfully with the SLC, the
proposed function of which is to select for m chains capable
of pairing with conventional L chains (19, 20). Inability to
form a functional m chain–SLC complex triggers attempts
to generate a compatible m protein by a recombination at
the second H chain allele or by H chain replacement with
an upstream VH segment via cryptic recombination signals
(21, 22). Indeed, the presence of a second yH1 allele in
mJH
2/2 mice doubled the number of pre B-II and mature
B cells.
The ability of the yH2 and yH2m YACs, with their ad-
ditional 61 VH genes, to restore normal B cell development
indicated that the limited VH gene repertoire on the yH1
YAC is the cause for the inefficient B cell development in
yH1;mJH
2/2 mice. The large VH gene complexity, even
when presented on only one yH2 allele, restored a wild-
type–like probability of productive H chain recombination
events and ensured a wide range of V gene specificities that
could form functional pre-BCR complexes.
The importance of VH gene specificity for formation of a
functional pre-BCR complex, and thus for the develop-
ment of the B cells expressing it, was suggested by previous
studies investigating the expression pattern of Ig transgenes
or specific mouse endogenous V genes. For example, adult
mouse pre B cells expressing VH81X or Q52 genes were
unable to progress efficiently to the CD432 stage due to
the failure of these VH genes to form functional pre-BCR
complexes that deliver signals required for further differen-
tiation (23–27).
The limited VH diversity on the yH1 YAC reduced sig-
nificantly the number of B cells that progressed from the
immature B220lom1 stage to the recirculating B220him1
Figure 7. Restoration of B cell development in bone marrow of Xeno-
Mouse II. Analysis of bone marrow (A–E) of wild-type (WT), DI (mJH
2/2;
mCk2/2), and XenoMouse II (hemizygous for yH2 and homozygous for
yK2). Four-color flow cytometry was performed using antibodies against
(A) B220 and mouse or human m; (B) c-kit and CD25 in the B2201m2
population gated from A; (C) forward scatter size distribution of the
B2201m2c-kit2CD251 population gated from B; (D) HSA and BP-1 in
the B2201CD431 gated population; and (E) mouse d and mouse m or
human d and human m in the B2201CD432 gated population. The per-
centage of positive cells within a quadrant or region is indicated. The data
shown are representative of multiple animals. The mean numbers of
B2201m2 cells in the bone marrow were 2.3 6 0.6 3 106 for wild-type
(n 5 3), 1.6 3 106 for DI (n 5 1), and 1.8 6 1.0 3 106 for XenoMouse
II (n 5 5). The mean numbers of B220lom1 cells in the bone marrow
were 0.8 6 0.2 3 106 for wild-type (n 5 3), 0 for DI (n 5 1), and 0.3 6
0.2 3 106 for XenoMouse II (n 5 5). The mean numbers of B220him1
cells in the bone marrow were 0.8 6 0.1 3 106 for wild-type (n 5 3), 0
for DI (n 5 1), and 0.3 6 0.1 3 106 for XenoMouse II (n 5 5).
Figure 8. Human m chains function to support B cell proliferation in
vitro. B cells were enriched from pooled suspensions of splenocytes from
wild-type, yH1;mJH
2/2, or yH2;mJH
2/2 mice, then stimulated to prolif-
erate in vitro using (A) LPS or (B) anti–mouse m or anti–human m F(ab9)2,
as described in Materials and Methods. The data are presented as total
cpm incorporated; bar indicates SEM. Background incorporation of
[3H]thymidine in nonstimulated cultures was 400–2,700 cpm.493 Green and Jakobovits
stage (Fig. 5). The reduced mature B cell population could
reflect elimination of B cells expressing autoreactive speci-
ficities, lack of specificities that trigger positive selection
and expansion, or impaired cell survival in the periphery.
This block at B cell maturation was relieved, although not
fully, by the yH2 YAC, suggesting a necessity for diverse
VH specificities to support efficient B cell maturation and
expansion. The reduced mature B cell population in yH2
mice compared with wild-type mice may reveal possible
deficiencies, such as a need for specificities of the human l
chain genes that comprise 40% of the repertoire presented
on human B cells (28). The existing mature B cell popula-
tion in yH1- and yH2-bearing mJH
2/2 mice indicates that
human m can be stably produced by the mouse B cells and
can be assembled with the mouse Iga and Igb to form a
functional BCR capable of receiving and transmitting ex-
tracellular differentiation and proliferation signals (Fig. 8).
Studies with the two human k chain YACs demon-
strated the critical role of Vk gene repertoire in efficient L
chain recombination, in production of functional IgMk
protein, and thus in proper B cell differentiation (Fig. 5).
yK1;mCk2/2 mouse strains, containing similar numbers of
functional Vk and Vl genes, provided a unique tool to
study the mechanisms underlying the regulation of L chain
isotype use. One allele of yK1, with only two functional
Vk genes, competed effectively with the two l chain al-
leles, each containing three functional V genes, and two
yK1 alleles dominated L chain use. The dominance of yK1
can be attributed not to a larger repertoire but rather to in-
trinsic structural differences between the human k and
mouse  l chain loci, such as the inferior l chain recombina-
tion signal sequences (29), thus favoring a stochastic model
for k/l usage (30). In yK2;mCk2/2 strains, the k to l
chain usage ratio equaled that of wild-type mice (16), indi-
cating that the structural elements controlling L chain use
are similar in humans and mice. The ability of yK2, with its
increased number of Vk genes, to restore a normal mouse
k to l ratio indicated the importance of Vk gene repertoire
for wild-type–like L chain recombination.
yK1 supported modest improvements in B cell reconsti-
tution in mCk2/2 mice (Figs. 3 and 5). In contrast, yK2,
with its 18 functional Vk genes, restored normal B cell de-
velopment. Therefore, the limited number of Vk genes on
yK1 is likely to be the reason for the low efficiency of pro-
ductive VkJk recombination events. Fewer Vk genes could
also potentially reduce the efficiency of k chain editing, a
valuable mechanism for rescuing incompatible k chain
specificities (31–34). Finally, the lower efficiency of recom-
bination by inversion associated with the functional Vk
genes on yK1 (35) could also contribute to the reduced
number of recombination products.
The importance of Vk gene specificity for B cell devel-
opment was suggested by previous studies with Ig trans-
genes. For example, a k transgene paired with the TG
transgene in a RAG-deficient background failed to gener-
ate a mature B cell compartment (7), in contrast to the sub-
stantial reconstitution we detected when the TG transgene
could pair with the normal mouse L chain repertoire (Fig.
2). Spanopoulou et al. also demonstrated that a mk trans-
gene derived from a native antibody was able to support
full reconstitution in RAG-deficient mice (7). In addition,
differential abilities of two VkJk constructs, in combination
with endogenous mouse H chains, to generate a mature B
cell compartment were proposed to originate from forma-
tion of incompatible specificities (36). The contribution of
gene number or complexity to the ability of Vk repertoire
to support normal B cell development can be evaluated
from comparison of our yK2;mCk2/2 strains, with 18 dif-
ferent Vk genes, to mCk2/2 mice homozygous for a YAC
containing 20 copies of the same 5 Vk genes, i.e., 100
functional Vk genes but with limited complexity. This
transgene restored B cell development to a degree similar
to that observed in yK1 homozygous strains, and clearly
less efficiently than the yK2 YAC, as judged by the hk1 B
cell population and the human k serum levels (37). There-
fore, the diversity of the Vk gene repertoire seems critical
for proper L chain regulation.
The XenoMouse I (yH1;yK1;DI) strain exhibited the
same developmental blocks at the pro B/pre B-I and small
pre B-II stages, and twofold improvement in B cell develop-
ment by the second yH1 allele, as observed in yH1;mJH
2/2
mice (Figs. 5 and 7). However, the impairment of B cell
development at Fractions D–F, stages associated with gen-
eration of sIg1 B cells, was more severe in XenoMouse I
than in either yH1;mJH
2/2 or yK1;mCk2/2 mice (Fig. 5),
likely due to the combined limitations associated with the
limited V gene repertoire on both the H and the k chain
YACs. These limitations may have further reduced both
the frequency of B cells with productive and compatible m
and k chains (38), and the ability of the B cells to progress
to mature HSAlod1 cells (Fig. 6). Consistent with our find-
ings, mice engineered with multicopy human Ig minigenes
containing four VH and four Vk genes exhibited low levels
of B cell reconstitution compared with wild-type mice (11).
In contrast to XenoMouse I, the XenoMouse II strains ex-
hibited wild-type–like B cell development similar to that
observed in yH2 or yK2 intermediate strains, demonstrat-
ing proper regulation of the H and k chain gene recombi-
nation and expression (Fig. 5).
Significant but not fully restored mature B cell popula-
tions were detected in the bone marrow and in the periph-
ery of XenoMouse II, exhibiting markers associated with B
cell maturation (HSAlod1). As stated previously, the lack of
complete reconstitution may stem from specific features of
the human antibody repertoire. For example, some of the
generated human antibody specificities may be recognized
as autoreactive by the mouse and trigger B cell elimination
in the bone marrow (39), or may have a decreased life-span
due to lack of appropriate antigen stimulation (for a review,
see references 20 and 40). Positive selection and expansion of
the mature B cell population could also be impaired by the
absence of specificities, such as those associated with the hu-
man Vl genes. Nevertheless, the existing mature B cells re-
spond properly to antigen stimulation in vivo, as demonstrated494 Regulation of B Cell Development by V Gene Complexity
by efficient class switching, somatic hypermutation, and gen-
eration of high-affinity antigen-specific human mAbs (10).
Our previous report demonstrated the critical role of a
large V gene repertoire in providing the diverse specificities
required for production of high-affinity human antibodies
against a broad spectrum of antigens (10). This report
proved that V gene complexity is also essential to support
efficient B cell development, and thus to reconstitute a
normal humoral immune system in Ig-inactivated mice.
The findings reported here suggest the utility of Xeno-
Mouse strains as a tool to elucidate the molecular mecha-
nisms underlying the shaping of the human antibody gene
repertoire during developmental and disease states that are
not accessible for analysis in humans, including differential
expression of V, D, and J genes, human H and k chain ed-
iting, and identification of autoreactive specificities.
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